TAOK2 and cancer: A molecular docking study revealed that the quinoline–benzimidazole hybrid with propylamine at the C-5 position of the benzimidazole moiety, compound 14e, had the highest affinity to inhibit TAO2 protein kinases, whose activity has been linked to DNA damage and cancer proliferation.